Primary record
Levonorgestrel Imp. H (EP); 13-Ethyl-6beta,17-dihydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one; Levonorgestrel Imp. H (Pharmeuropa); 6beta-Hydroxylevonorgestrel; Levonorgestrel Impurity H
- 库存
- 2,294 克
- 纯度
- 98.8 %
- CAS
- 55555-97-0
化合物标识与属性
- CAS
- 55555-97-0
- PubChem CID
- 129318271
- SMILES
- CC[C@]12CC[C@@H]3[C@H]4CCC(=O)C=C4[C@@H](C[C@H]3[C@@H]1CC[C@]2(C#C)O)O
- Canonical SMILES
- C#C[C@]1(O)CC[C@H]2[C@@H]3C[C@@H](O)C4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21CC
名称与同义词
- 6beta-Hydroxylevonorgestrel
- 6beta-Hydroxy Norgestrel
- 6b-Hydroxylevonorgestrel
- 6|A-Hydroxy Norgestrel
- Levonorgestrel EP Impurity H
- 6b-Hydroxy Norgestrel
- 55555-97-0
- Y643AOR6HN
- rac 6b-Hydroxy Norgestrel
- UNII-Y643AOR6HN
- Levonorgestrel impurity H
- RefChem:199139
- 6|A-Hydroxylevonorgestrel
- rac 6beta-Hydroxy Norgestrel
- 579EVS2GNR
- Levonorgestrel impurity H [EP]
- 6.BETA.-HYDROXYLEVONORGESTREL
- C21H28O3
- MFCD19053183
- ZINC65742827
- AKOS032958180
- Norgestrel impurity C [EP IMPURITY]
- FH171973
- LEVONORGESTREL IMPURITY H [EP IMPURITY]
- FT-0669392
- (6R,8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-6,17-dihydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
- G91039
- LEVONORGESTREL IMPURITY H (EP IMPURITY)
- Levonorgestrel Impurity H (6-beta-Hydroxy Levonorgestrel)
- (6beta,17alpha)-13-Ethyl-6,17-dihydroxy-18,19-dinorpregn-4-en-20-yn-3-one
- 13-Ethyl-6beta,17-dihydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one
- (6.BETA.,17.ALPHA.)-13-ETHYL-6,17-DIHYDROXY-18,19-DINORPREGN-4-EN-20-YN-3-ONE
- 13-Ethyl-6,17-dihydroxy-18,19-dinor-17-pregn-4-en-20-yn-3-one
- 13-ETHYL-6.BETA.,17-DIHYDROXY-18,19-DINOR-17.ALPHA.-PREGN-4-EN-20-YN-3-ONE
- 18,19-Dinorpregn-4-en-20-yn-3-one, 13-ethyl-6,17-dihydroxy-, (6beta,17alpha)-
- 18,19-DINORPREGN-4-EN-20-YN-3-ONE, 13-ETHYL-6,17-DIHYDROXY-, (6.BETA.,17.ALPHA.)-
- 20402-61-3
- 18,19-Dinor-17alpha-pregn-4-en-20-yn-3-one, 13-ethyl-6beta,17-dihydroxy-, (+/-)-
- 18,19-Dinorpregn-4-en-20-yn-3-one, 13-ethyl-6,17-dihydroxy-, (6beta,17alpha)-(+/-)-
- rac-13-Ethyl-6beta,17-dihydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one
- (6beta,17alpha)-(+/-)-13-Ethyl-6,17-dihydroxy-18,19-dinorpregn-4-en-20-yn-3-one; (+/-)-13-Ethyl-6beta,17-dihydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one
- (6R,8R,9S,10R,13R,14S,17R)-13-ethyl-17-ethynyl-6,17-dihydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
- (6R,8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-6,17-dihydroxy-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3(2H)-one
- 13-Ethyl-6beta,17-dihydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one (6beta-Hydroxylevonorgestrel)
- Levonorgestrel Imp. H (EP); 13-Ethyl-6beta,17-dihydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one; Levonorgestrel Imp. H (Pharmeuropa); 6beta-Hydroxylevonorgestrel; Levonorgestrel Impurity H